---
figid: PMC8422427__physrev.00030.2020_f006
figtitle: 'Obesity cardiomyopathy: evidence, mechanisms, and therapeutic implications'
organisms:
- NA
organisms_ner:
- Danio rerio
- Homo sapiens
pmcid: PMC8422427
filename: physrev.00030.2020_f006.jpg
figlink: /pmc/articles/PMC8422427/figure/F0006/
number: F6
caption: 'Obesity-mediated endoplasmic reticulum (ER) stress underlies cardiometabolic
  disorders: Obesity induces certain conditions such as hyperglyceridemia, glycemia,
  insulin resistance, and macrophage activation, all of which, in turn switches on
  several pathways culminating in ER stress, inflammation, and ultimately cardiometabolic
  disorders. Insulin resistance induces ER stress, which activates three branches
  of unfolded protein response (UPR) including ATF6, PERK, and IRE-1α. IRE-1α/TRAF2/JNK1/c-Jun
  pathway induces inflammation via TNF-α and IL-6, while PERK/eIF2α/IκBα pathway and
  ATF6 trigger NF-κB complex-mediated inflammation. Macrophage also produces IL-1β,
  which activates IKK and NF-κB complexes leading to inflammation. Hyperglyceridemia
  and glycemia induce carbotoxicity and lipotoxicity, which instigates metabolic alterations
  resulting in ER stress and inflammation. IRE-1α, inositol-requiring protein-1; PERK,
  protein kinase RNA-like ER kinase; ATF6, activating transcription factor-6; IKK,
  I-κb-kinase; NF-κB, nuclear factorκB; IκBα, I-κb-α; Ub, ubiquitin; eIF2α, eukaryotic
  initiation factor 2α; Nrf-2, nuclear factor-E2-related factor; XBP1s, X-box-binding-protein-1
  spliced; TRAF2, TNF receptor-associated factor 2; JNK1, C-Jun NH2-terminal kinase
  1; ATF4, activating transcription factor-4; FOXO, forkhead box O; c-Jun, a transcription
  factor; CHOP, C/EBP homologous protein; FA, fatty acid; Glu, glucose; GLUT4, glucose
  transporter type 4; DAG, diacylglycerol; O-GlcNAc, β-linked N-acetylglucosamine;
  AGEs, advanced glycation end-products.'
papertitle: 'Obesity cardiomyopathy: evidence, mechanisms, and therapeutic implications.'
reftext: Jun Ren, et al. Physiol Rev. 2021 Oct 1;101(4):1745-1807.
year: '2021'
doi: 10.1152/physrev.00030.2020
journal_title: Physiological Reviews
journal_nlm_ta: Physiol Rev
publisher_name: American Physiological Society
keywords: cardiovascular disease | glucotoxicity | heart | inflammation | lipotoxicity
  | obesity | therapy
automl_pathway: 0.9564412
figid_alias: PMC8422427__F6
figtype: Figure
redirect_from: /figures/PMC8422427__F6
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8422427__physrev.00030.2020_f006.html
  '@type': Dataset
  description: 'Obesity-mediated endoplasmic reticulum (ER) stress underlies cardiometabolic
    disorders: Obesity induces certain conditions such as hyperglyceridemia, glycemia,
    insulin resistance, and macrophage activation, all of which, in turn switches
    on several pathways culminating in ER stress, inflammation, and ultimately cardiometabolic
    disorders. Insulin resistance induces ER stress, which activates three branches
    of unfolded protein response (UPR) including ATF6, PERK, and IRE-1α. IRE-1α/TRAF2/JNK1/c-Jun
    pathway induces inflammation via TNF-α and IL-6, while PERK/eIF2α/IκBα pathway
    and ATF6 trigger NF-κB complex-mediated inflammation. Macrophage also produces
    IL-1β, which activates IKK and NF-κB complexes leading to inflammation. Hyperglyceridemia
    and glycemia induce carbotoxicity and lipotoxicity, which instigates metabolic
    alterations resulting in ER stress and inflammation. IRE-1α, inositol-requiring
    protein-1; PERK, protein kinase RNA-like ER kinase; ATF6, activating transcription
    factor-6; IKK, I-κb-kinase; NF-κB, nuclear factorκB; IκBα, I-κb-α; Ub, ubiquitin;
    eIF2α, eukaryotic initiation factor 2α; Nrf-2, nuclear factor-E2-related factor;
    XBP1s, X-box-binding-protein-1 spliced; TRAF2, TNF receptor-associated factor
    2; JNK1, C-Jun NH2-terminal kinase 1; ATF4, activating transcription factor-4;
    FOXO, forkhead box O; c-Jun, a transcription factor; CHOP, C/EBP homologous protein;
    FA, fatty acid; Glu, glucose; GLUT4, glucose transporter type 4; DAG, diacylglycerol;
    O-GlcNAc, β-linked N-acetylglucosamine; AGEs, advanced glycation end-products.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - xbp1
  - mapk8b
  - nfe2l2a
  - atf4a
  - elf2a
  - eif2a
  - atf6
  - nfkb1
  - nfkb2
  - jun
  - il1b
  - il1rl1
  - ikbkg
  - tnfb
  - il6
  - XBP1
  - XBP1P1
  - ERN1
  - TRAF2
  - TANK
  - MAPK8
  - NFE2L2
  - EIF2AK3
  - ATF4
  - EIF2A
  - EIF2S1
  - FOXO1
  - FOXO3
  - FOXO4
  - FOXO6
  - DDIT3
  - ATF6
  - OGT
  - NFKB1
  - CHUK
  - IKBKB
  - IKBKG
  - IKBKE
  - TBK1
  - NFKB2
  - JUN
  - LPL
  - SLC2A4
  - IL1B
  - IL1R1
  - TNF
  - IL6
---
